Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Advocating for Mainstreaming Psychedelic Therapies to Treat Mental Health Conditions with Dr. Steve Xenakis American Psychedelic Practitioners Association TRANSCRIPT

Download PDF

Dec 19, 2023

Retired Brigadier General Dr. Steve Xenakis is Executive Director of the American Psychedelic Practitioners Association, a group of clinicians who are interested in developing and promoting the mainstream use of psychedelic and plant medicines for the treatment of mental health conditions. APPA works to...

Advocating for Mainstreaming Psychedelic Therapies to Treat Mental Health Conditions with Dr. Steve Xenakis American Psychedelic Practitioners Association

Dec 19, 2023

Lead Compound Targets Neuroinflammation Slowing Alzheimer’s Progression with Jeffrey Madden ADvantage Therapeutics TRANSCRIPT

Download PDF

Dec 18, 2023

Jeffrey Madden, Co-Founder and CEO of ADvantage Therapeutics is developing therapies for neurodegenerative conditions, particularly Alzheimer's disease. Instead of pursuing the amyloid hypothesis, ADvantage is focused on neuroinflammation as the primary driver of Alzheimer's pathology. Trials for their lead compound...

Lead Compound Targets Neuroinflammation Slowing Alzheimer’s Progression with Jeffrey Madden ADvantage Therapeutics

Dec 18, 2023

Novel Antiviral Drug Shows Promise Treating Norovirus with Dr. Sam Lee Cocrystal Pharma TRANSCRIPT

Download PDF

Dec 18, 2023

Dr. Sam Lee, Co-CEO of Cocrystal Pharma, discusses novel antiviral therapeutics to treat norovirus. This highly contagious virus causes acute gastroenteritis, and there is no known treatment or vaccine. Cocrystal is developing a compound that targets the essential enzymes of the virus, showing promising results...